These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. Nara K, Kusafuka T, Yoneda A, Oue T, Sangkhathat S, Fukuzawa M. Int J Oncol; 2007 May 08; 30(5):1189-96. PubMed ID: 17390021 [Abstract] [Full Text] [Related]
8. MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis. Slack A, Lozano G, Shohet JM. Cancer Lett; 2005 Oct 18; 228(1-2):21-7. PubMed ID: 15927364 [Abstract] [Full Text] [Related]
9. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells. Cortés C, Kozma SC, Tauler A, Ambrosio S. Cell Oncol (Dordr); 2015 Oct 18; 38(5):341-52. PubMed ID: 26306783 [Abstract] [Full Text] [Related]
10. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma. Schramm A, Köster J, Marschall T, Martin M, Schwermer M, Fielitz K, Büchel G, Barann M, Esser D, Rosenstiel P, Rahmann S, Eggert A, Schulte JH. Int J Cancer; 2013 Feb 01; 132(3):E106-15. PubMed ID: 22907398 [Abstract] [Full Text] [Related]
17. Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma. He J, Gu L, Zhang H, Zhou M. Cell Cycle; 2011 Sep 01; 10(17):2994-3002. PubMed ID: 21862876 [Abstract] [Full Text] [Related]
18. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration. Zaatiti H, Abdallah J, Nasr Z, Khazen G, Sandler A, Abou-Antoun TJ. Int J Oncol; 2018 Mar 01; 52(3):787-803. PubMed ID: 29328367 [Abstract] [Full Text] [Related]
19. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line. Chevrier L, Meunier AC, Cochaud S, Muller JM, Chadéneau C. Int J Oncol; 2008 Nov 01; 33(5):1081-9. PubMed ID: 18949372 [Abstract] [Full Text] [Related]
20. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3. Fabian J, Lodrini M, Oehme I, Schier MC, Thole TM, Hielscher T, Kopp-Schneider A, Opitz L, Capper D, von Deimling A, Wiegand I, Milde T, Mahlknecht U, Westermann F, Popanda O, Roels F, Hero B, Berthold F, Fischer M, Kulozik AE, Witt O, Deubzer HE. Cancer Res; 2014 May 01; 74(9):2604-16. PubMed ID: 24419085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]